Search

Search Constraints

You searched for: Author/Creator Tobe, Sheldon

Search Results

1. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial. Issue 10184 (11th May 2019)

2. Baseline characteristics and enrichment results from the SONAR trial. Issue 8 (1st May 2018)

4. Organic Anion Transporter Gene Variants Associated With Plasma Exposure and Long‐Term Response to Atrasentan in Patients With Diabetic Kidney Disease. Issue 5 (11th August 2022)

5. Prediction of the effect of atrasentan on renal and heart failure outcomes based on short-term changes in multiple risk markers. (29th August 2020)

6. Prediction of the effect of atrasentan on renal and heart failure outcomes based on short-term changes in multiple risk markers. (May 2016)

7. Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy. Issue 6 (9th March 2018)

8. Relationship of Albuminuria and Renal Artery Stent Outcomes: Results From the CORAL Randomized Clinical Trial (Cardiovascular Outcomes With Renal Artery Lesions). Issue 5 (November 2016)

10. The Effect of Atrasentan on Kidney and Heart Failure Outcomes by Baseline Albuminuria and Kidney Function: A Post Hoc Analysis of the SONAR Randomized Trial. Issue 12 (December 2021)